Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00145197 · ClinicalTrials.gov registry record · NA
Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 1,164
- Enrollment target
NCT00145197 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,164 participants.
The verdict
NCT00145197, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,164 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a physician-centered intervention will help women with early stage breast cancer receive appropriate treatment.
Interventions
- BEHAVIORAL Improving the Delivery of Effective Care to Minorities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,164 participants |
| Start Date | 2004-01 |
| Est. Completion | 2007-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00145197
The ClinicalTrials.gov registry entry for NCT00145197 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Improving the Delivery of Effective Care to Minorities is the first listed.
NCT00145197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00145197 about?
NCT00145197 is a clinical study titled "Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities". The purpose of this study is to determine if a physician-centered intervention will help women with early stage breast cancer receive appropriate treatment.
What is the current status of trial NCT00145197?
This trial is currently completed. It is a NA study. The enrollment target is 1,164 participants. The study started on 2004-01. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00145197?
The interventions under investigation include: Improving the Delivery of Effective Care to Minorities (BEHAVIORAL).
Who is sponsoring clinical trial NCT00145197?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.